Johnson & Johnson

Top drugmaker sticks to forecasts as earnings beat expectations but pencils in $400m hit from tariff impact on medical device business

Mark Keane (43) brought personal injury case against former employer over 2018 incident at plant in Plassey

Pharma companies ‘disappointed’ in Government’s stance during EU negotiations

Mark Keane (34) alleges he has suffered with pain ever since September 2018 incident

Mark Keane, who is taking High Court action against Johnson & Johnson, has not worked since sustaining injuries

It was a challenging year for some listed companies and a record year for CEO departures

Narrative verdict returned at inquest into death of Roy Butler (23) five days after receiving Janssen Covid-19 vaccine

Representative of pharma company tells inquest of Roy Butler (23) he does not know have data on how many people died after receiving jab

Counsel for Roy Butler’s family notes 59 people suffered intercranial bleeds after having Janssen jab, which company says was out of a total of 616 million doses

Revenue from the business tax generated €23.8 billion last year, equivalent to €5,000 for every man, woman and child in the State

Despite more than 40,000 people in Ireland living with inflammatory bowel disease, it is still not widely spoken about

Courts have rebuffed company’s two previous efforts to resolve the lawsuits

Quarterly revenue hit $21.40bn, above market expectations of $21.01bn

Pharmaceutical-related products accounted for almost two-thirds of Irish goods exports last year

President argues Americans pay far too much for their drugs but the power of pharma stands in his way

Banks struggle as investors register concern about the outlook for the euro-zone economy

Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades

Cork native talks FDI, employee ownership and work-life balance ahead of his retirement

Artificial intelligence could transform the sector, and not everyone subscribes to gloomy forecasts

West Pharmaceutical Services says initiative can make Ireland ‘a powerful exponent’ in new digital technologies

More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out

Euronext Dublin outperforms European peers as a number of its heavy hitters drag it up almost 1.5%

Healthcare company tries to put thousands of lawsuits behind it with latest offer to plaintiffs

Revenues rise 9.5% to €1.04bn

Euronext Dublin outperforms international peers on the back of 3 per cent climb by Ryanair

The year was dominated by rollercoaster news stories such as Elon Musk’s turbulent takeover of Twitter, the downfall of Elizabeth Holmes and the numerous cryptocurrency scandals

Agency’s figures also point to partial displacement of trade following UK’s exit from EU

Dublin-headquartered group develops treatments for rare diseases

Most of firm's revenue came from outside Ireland

In a staggering level of exposure 10 per cent of all tax revenue in Ireland is now coming from just 10 American corporations

Group said it hopes to hire 80 new staff at contact lens plant in Plassey, with recruitment under way

A 2018 Reuters investigation found J&J knew for decades that asbestos, a carcinogen, was present in its talc products

Parent company J&J makes almost €420m in net provisions for personal injury claims relating to the antipsychotic drug

Company, part of the Johnson and Johnson Group, specialises in neurovascular care

CEO expects early supplies to be used for Covax supplies as analysts eye shot as booster option

HSE to outline next phase of rollout which will see 400,000 vaccinations a week in June

Allowing J&J for over 50s, along with change in AstraZeneca guidelines, to accelerate vaccinations

No Covid-related deaths reported in the group vaccinated in clinical trial

Review process that could lead to millions more doses becoming available to take place

Johnson & Johnson to ship some Covid-19 vaccines ordered by EU to US for fill/finish